M

02629

Mirxes Holding

Upcoming IPOs
Listing Date: --
Filed
Offering
Price Range

Pending

Shares to be Issued

Pending

Offering End Date
Offering Price

Pending

Post IPO Outstanding

Pending

Listed
P/E (FWD)--
P/B--
P/S--
MARKET CAP--
INDUSTRY--
News
Press Releases
Financial Reports
Profile
    Same Industry
    Name/Symbol
    Change%
    Price

    S

    Shanghai Haohai Biological Technology

    06826

    +0.43%
    23.450

    W

    Wuxi Apptec

    02359

    -0.94%
    63.200

    H

    Hangzhou Tigermed Consulting

    03347

    -5.23%
    25.350

    J

    JOINN Laboratories (China)

    06127

    +0.31%
    9.700

    P

    Pharmaron Beijing

    03759

    -0.45%
    13.400

    F

    Frontage Holdings

    01521

    0.00%
    1.150

    B

    BBI Life Sciences

    01035

    0.00%
    3.490

    C

    China Health Group

    08225

    0.00%
    0.160

    M

    Mingyuan Medicare Development

    00233

    0.00%
    0.230

    C

    China Regenerative Medicine International

    08572

    --
    0.010

    M

    Mabpharm

    02181

    0.00%
    0.435

    V

    Viva Biotech Holdings

    01873

    +10.69%
    1.760

    C

    China Regenerative Medicine International

    08158

    -1.25%
    0.395

    T

    TOT Biopharm International

    01875

    0.00%
    1.880

    H

    Hua Medicine

    02552

    +1.46%
    2.090

    M

    MicroPort NeuroScientific

    02172

    -1.15%
    10.360

    A

    Alphamab Oncology

    09966

    +1.06%
    6.700

    S

    SinoMab BioScience

    03681

    +1.56%
    1.300

    L

    Lepu Biopharma

    02157

    +0.23%
    4.410

    J

    Jacobio Pharmaceuticals Group

    01167

    -2.50%
    4.290
    Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
    During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
    Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
    Language

    English

    ©2025 Webull Securities Limited. All rights reserved.